Marshall Wace’s Blend Labs BLND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Sell
1,731,356
-10,951
-0.6% -$23.4K ﹤0.01% 1578
2025
Q4
$5.3M Buy
1,742,307
+284,549
+20% +$908K ﹤0.01% 1131
2025
Q3
$5.32M Sell
1,457,758
-1,064,383
-42% -$3.82M 0.01% 1159
2025
Q2
$8.32M Buy
2,522,141
+1,543,220
+158% +$5.23M 0.01% 924
2025
Q1
$3.28M Buy
978,921
+451,239
+86% +$1.64M ﹤0.01% 1242
2024
Q4
$2.22M Buy
527,682
+169,953
+48% +$731K ﹤0.01% 1394
2024
Q3
$1.34M Sell
357,729
-557,583
-61% -$1.85M ﹤0.01% 1526
2024
Q2
$2.16M Sell
915,312
-319,970
-26% -$848K ﹤0.01% 1332
2024
Q1
$4.01M Buy
+1,235,282
New +$3.33M 0.01% 1088
2023
Q3
Sell
-51,193
Closed -$48.6K 2209
2023
Q2
$48.6K Buy
+51,193
New +$45.4K ﹤0.01% 2372
2022
Q3
Sell
-839,847
Closed -$1.98M 3350
2022
Q2
$1.98M Buy
839,847
+815,818
+3,395% +$3.05M ﹤0.01% 2004
2022
Q1
$137K Buy
+24,029
New +$186K ﹤0.01% 3154
2021
Q4
Sell
-17,278
Closed -$233K 3867
2021
Q3
$233K Buy
+17,278
New +$293K ﹤0.01% 2746

Other funds holding BLND

Marshall Wace's BLND Position: Q1 2026 in Review

Marshall Wace reduced its Blend Labs (BLND) stake by 0.63% in Q1 2026, selling an estimated $23.4K and leaving 1,731,356 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

Marshall Wace first reported a position in BLND in Q3 2021 and has held it in 13 quarters since. The position peaked at $8.32M in Q2 2025. 194 funds tracked by Wall St. Rank hold BLND as of Q1 2026.

  • Marshall Wace held 1,731,356 shares of Blend Labs worth $2.94M as of Q1 2026.
  • Marshall Wace sold 10,951 Blend Labs shares in Q1 2026, an estimated $23.4K.
  • Blend Labs made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1578 holding.
  • Marshall Wace first reported a position in Blend Labs in Q3 2021 and has held it in 13 quarters since.
  • Marshall Wace's Blend Labs position peaked at $8.32M in Q2 2025.
  • 194 funds tracked by Wall St. Rank held Blend Labs as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.